Do not administer as an intravenous push or bolus. Administer only as an intravenous (IV) infusion.
Patients should continue treatment until disease progression or unacceptable toxicity.
The recommended doses are 5 mg/kg or 10 mg/kg every 2 weeks when used in combination with intravenous 5-FU-based chemotherapy.
The recommended dose is 15 mg/kg every 3 weeks in combination with carboplatin and paclitaxel.
The recommended dose is 10 mg/kg every 2 weeks.
The recommended dose is 10 mg/kg every 2 weeks in combination with interferon alfa.
The recommended dose of Avastin is 15 mg/kg every 3 weeks as an intravenous infusion administered in combination with one of the following chemotherapy regimens: paclitaxel and cisplatin, or paclitaxel and topotecan.
The recommended dose is 10mg/kg every 2 weeks in combination with one of the following intravenous chemotherapy regimens: paclitaxel, pegylated liposomal doxorubicin, or topotecan (weekly); or 15 mg/kg every 3 weeks in combination with topotecan (every 3 weeks).
Use appropriate aseptic technique. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. Withdraw necessary amount of Avastin and dilute in a total volume of 100 mL of 0.9% Sodium Chloride Injection, USP. Discard any unused portion left in a vial, as the product contains no preservatives.
DO NOT ADMINISTER OR MIX WITH DEXTROSE SOLUTION.
There are no recommended dose reductions.
Discontinue Avastin for:
Temporarily suspend Avastin for:
